114 related articles for article (PubMed ID: 37399803)
21. microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells.
Zhang H; Qi M; Li S; Qi T; Mei H; Huang K; Zheng L; Tong Q
Mol Cancer Ther; 2012 Jul; 11(7):1454-66. PubMed ID: 22564723
[TBL] [Abstract][Full Text] [Related]
22. Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma.
Rihani A; Van Goethem A; Ongenaert M; De Brouwer S; Volders PJ; Agarwal S; De Preter K; Mestdagh P; Shohet J; Speleman F; Vandesompele J; Van Maerken T
Sci Rep; 2015 Mar; 5():9027. PubMed ID: 25762502
[TBL] [Abstract][Full Text] [Related]
23. miR-34a inhibits progression of neuroblastoma by targeting autophagy-related gene 5.
Cheng X; Xu Q; Zhang Y; Shen M; Zhang S; Mao F; Li B; Yan X; Shi Z; Wang L; Sheng G; Zhang Q
Eur J Pharmacol; 2019 May; 850():53-63. PubMed ID: 30716314
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
Gong P; Zhang T; He D; Hsieh JT
Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles.
Tivnan A; Orr WS; Gubala V; Nooney R; Williams DE; McDonagh C; Prenter S; Harvey H; Domingo-Fernández R; Bray IM; Piskareva O; Ng CY; Lode HN; Davidoff AM; Stallings RL
PLoS One; 2012; 7(5):e38129. PubMed ID: 22662276
[TBL] [Abstract][Full Text] [Related]
26. The miR-34a-5p-c-MYC-CHK1/CHK2 Axis Counteracts Cancer Stem Cell-Like Properties and Enhances Radiosensitivity in Hepatocellular Cancer Through Repression of the DNA Damage Response.
Zhao X; Zhuang Y; Wang B; Yuan B; Du S; Zeng Z
Radiat Res; 2023 Jan; 199(1):48-60. PubMed ID: 36445955
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
Buechner J; Henriksen JR; Haug BH; Tømte E; Flaegstad T; Einvik C
Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
[TBL] [Abstract][Full Text] [Related]
28. Expression patterns of microRNAs are altered in hypoxic human neuroblastoma cells.
Yamagata T; Yoshizawa J; Ohashi S; Yanaga K; Ohki T
Pediatr Surg Int; 2010 Dec; 26(12):1179-84. PubMed ID: 20809117
[TBL] [Abstract][Full Text] [Related]
29. 125I radiation downregulates TRPV1 expression through miR‑1246 in neuroblastoma cells.
Zhang D; Xu H; Wang Y; Wang K; Wang Y; Wu B; Zhu J; Peng L; Gao J; Li Z
Oncol Rep; 2019 Jul; 42(1):243-252. PubMed ID: 31059092
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis
Zhao J; Zhou K; Ma L; Zhang H
Bioengineered; 2020 Dec; 11(1):219-228. PubMed ID: 32083506
[TBL] [Abstract][Full Text] [Related]
31. Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells.
Chakrabarti M; Khandkar M; Banik NL; Ray SK
Brain Res; 2012 May; 1454():1-13. PubMed ID: 22498172
[TBL] [Abstract][Full Text] [Related]
32. The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression.
Zhao Z; Shelton SD; Oviedo A; Baker AL; Bryant CP; Omidvarnia S; Du L
J Exp Clin Cancer Res; 2020 Feb; 39(1):41. PubMed ID: 32087738
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.
Soriano A; París-Coderch L; Jubierre L; Martínez A; Zhou X; Piskareva O; Bray I; Vidal I; Almazán-Moga A; Molist C; Roma J; Bayascas JR; Casanovas O; Stallings RL; Sánchez de Toledo J; Gallego S; Segura MF
Oncotarget; 2016 Feb; 7(8):9271-87. PubMed ID: 26824183
[TBL] [Abstract][Full Text] [Related]
34. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA SNHG7 promotes neuroblastoma progression through sponging miR-323a-5p and miR-342-5p.
Jia J; Zhang D; Zhang J; Yang L; Zhao G; Yang H; Wang J
Biomed Pharmacother; 2020 Aug; 128():110293. PubMed ID: 32534305
[TBL] [Abstract][Full Text] [Related]
36. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
[TBL] [Abstract][Full Text] [Related]
37. Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma.
Soriano A; Masanas M; Boloix A; Masiá N; París-Coderch L; Piskareva O; Jiménez C; Henrich KO; Roma J; Westermann F; Stallings RL; Sábado C; de Toledo JS; Santamaria A; Gallego S; Segura MF
Cell Mol Life Sci; 2019 Jun; 76(11):2231-2243. PubMed ID: 30770954
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA expression and clinical outcome of small cell lung cancer.
Lee JH; Voortman J; Dingemans AM; Voeller DM; Pham T; Wang Y; Giaccone G
PLoS One; 2011; 6(6):e21300. PubMed ID: 21731696
[TBL] [Abstract][Full Text] [Related]
39. A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells.
Zhao Z; Ma X; Shelton SD; Sung DC; Li M; Hernandez D; Zhang M; Losiewicz MD; Chen Y; Pertsemlidis A; Yu X; Liu Y; Du L
Oncotarget; 2016 Nov; 7(48):79372-79387. PubMed ID: 27764804
[TBL] [Abstract][Full Text] [Related]
40. Reciprocal antagonistic regulation of N-myc mRNA by miR‑17 and the neuronal-specific RNA-binding protein HuD.
Samaraweera L; Spengler BA; Ross RA
Oncol Rep; 2017 Jul; 38(1):545-550. PubMed ID: 28560387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]